GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

NCT04456998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Artery Hypertension

Interventions

DRUG: GB002 (seralutinib)
DRUG: Placebo
DEVICE: Generic Dry Powder Inhaler

Sponsor

GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.